![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Issue contents]](/e/graphics/issuecontentsborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](hb2445contents.gif)
Acta Cryst. (2007). E63, m1984 [ doi:10.1107/S1600536807030309 ]
![[mu]](/logos/entities/mu_rmgif.gif)
2-acetato-2-benzimidazolato-zinc(II)]Abstract: The title compound, [Zn(C7H5N2)(C2H3O2)]n, was obtained unintentionally as the product of an attempted synthesis of a polycarboxylate-bridged network complex of zinc(II) using naphthalene-1,4,5,8-tetracarboxylic acid as the organic acid. The Zn atom is four-coordinated by two O atoms from two acetate (OAc) ligands and two N atoms from two different benzimidazole (bzim) ligands, resulting in a ZnN2O2 tetrahedron. The OAc and bzim ligands bridge the Zn atoms to form an infinite three-dimensional network.
Online 27 June 2007
Copyright © International Union of Crystallography
IUCr Webmaster